Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 132.94M P/E - EPS this Y 4.20% Ern Qtrly Grth -
Income -89.14M Forward P/E -1.67 EPS next Y 10.80% 50D Avg Chg -47.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 0.81 EPS next 5Y - 52W High Chg -72.00%
Recommedations 1.60 Quick Ratio 7.30 Shares Outstanding 32.59M 52W Low Chg 29.00%
Insider Own 0.02% ROA -31.89% Shares Float 15.48M Beta 1.71
Inst Own 92.42% ROE -58.97% Shares Shorted/Prior 0.97M/808.86K Price 5.59
Gross Margin - Profit Margin - Avg. Volume 65,759 Target Price 19.60
Oper. Margin - Earnings Date - Volume 118,668 Change -5.89%
About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

PepGen Inc. News
04:05 PM PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
11/07/24 PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/06/24 We're Keeping An Eye On PepGen's (NASDAQ:PEPG) Cash Burn Rate
11/04/24 PepGen to Participate in Upcoming Investor Conferences
10/08/24 PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
09/19/24 PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
08/20/24 PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
08/20/24 PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
08/17/24 Is PepGen Inc. (NASDAQ:PEPG) Trading At A 34% Discount?
08/08/24 PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
08/02/24 Down -39.63% in 4 Weeks, Here's Why You Should You Buy the Dip in PepGen (PEPG)
07/31/24 PepGen reports positive data from Phase II Duchenne muscular dystrophy trial
07/30/24 PepGen Announces Positive Data from Low-Dose Cohort of PGN-EDO51 in Ongoing CONNECT1-EDO51 Phase 2 Clinical Trial for Treatment of Duchenne Muscular Dystrophy
07/17/24 Recent Price Trend in PepGen (PEPG) is Your Friend, Here's Why
07/02/24 PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications
06/11/24 PepGen Announces Executive Team Promotions
05/22/24 We're Not Very Worried About PepGen's (NASDAQ:PEPG) Cash Burn Rate
05/14/24 PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
04/25/24 Best Momentum Stocks to Buy for April 25th
03/13/24 PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
PEPG Chatroom

User Image TheLearnerEarner Posted - 2 days ago

$PEPG ✅ BARGAIN stock swing trade - healthcare - small cap - 3/9 F-Score - 0.34x relative volume - 2x analysts outperform rating - 2x analysts buy rating - has more assets than liabilities - short term gains (with potential for a medium term upgrade) 💱 RSI: 18.20 (oversold heavily) 📊⚓ Analysts Price Target: $21.00 - $27.30 (403% - 551% above Price) 🌟 Range (12m) $4.00 - $19.30 💰 NEWSDESK (last recent article) 📰 https://uk.finance.yahoo.com/news/pepgen-reports-third-quarter-2024-130000684.html

User Image Goingupnow1 Posted - 2 days ago

$PEPG 170 million in cash, cash equivalent and marketable securities. 32 million shares outstanding. this is trading at less book value.

User Image erevnon Posted - 3 days ago

B of A Securities maintains PepGen $PEPG at Neutral and lowers the price target from $10 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Butters_Stotch1 Posted - 1 week ago

$PEPG well this is painful…yikes guess I’ll be waiting on this one for a while

User Image anachartanalyst Posted - 1 week ago

$PEPG https://anachart.com/wp-content/uploads/ana_temp/1731081796_soc-img.jpg

User Image Butters_Stotch1 Posted - 10/31/24

$PEPG averaged down again… my last time

User Image PenkeTrading Posted - 10/26/24

I found you an Oversold RSI (Relative Strength Index) on the daily chart of PepGen Ltd. Is that bullish or bearish? $PEPG #PepGen #RsiOversold #NASDAQ

User Image Butters_Stotch1 Posted - 1 month ago

$PEPG up 9 percent, I’ll bail at 10.50

User Image Butters_Stotch1 Posted - 2 months ago

$PEPG I was hoping for more good red days to keep scaling but green will do

User Image Butters_Stotch1 Posted - 2 months ago

$PEPG 520 shares at 9.46 averaged down on that dip

User Image Butters_Stotch1 Posted - 2 months ago

$PEPG started a small potion here 260 shares at 9.71.

User Image Butters_Stotch1 Posted - 2 months ago

$GLTO going to start a position on Monday. I will also look at $PEPG

User Image intratio Posted - 3 months ago

PepGen Inc. Our model judges this stock s price will plummet in in the coming week and has really poor long-term fundamentals $PEPG

User Image intratio Posted - 3 months ago

$PEPG https://www.intratio.com/stock-forecast/PEPG Our predictive algorithm computed this equity s value will plummet in in the coming week and is facing massive downsides in the longer term

User Image BioGem Posted - 3 months ago

You seem very short-term oriented unless you are a trader. Have you looked at their latest skyrocketing operating losses and huge jump in current liabilities? This means that cash burn will accelerate significantly toward the end of 2024. Let's recheck the stock price then. Add that more competitors are releasing good data lately. $PEPG

User Image intratio Posted - 3 months ago

https://www.intratio.com/stock-forecast/PEPG The algorithm computed this company s stock price will soon start to trend dramatically lower and is poised to drop further in the coming weeks $PEPG

User Image intratio Posted - 3 months ago

$PEPG https://www.intratio.com/stock-forecast/PEPG The predictive model assessed this equity s value will instantly and significantly lessen also clearly lacks long-term fundamentals

User Image BioGem Posted - 3 months ago

$PEPG I wouldn't invest in this name for several reasons: -Their niche is crowded with competitors who have proven better scientific results in DMD. -Their next catalyst in Q2 (Freedom trial) is for phase 1 trial, which will not move the needle much. -Cash burn is high and will accelerate with the launch of the Connect 2 trial, so more dilution is expected in 2025. -Their trials are not running in the USA yet and that needs to be addressed if the FDA will consider an approval in the distant future.

User Image Fullratio Posted - 3 months ago

$PEPG current ratio has shrunk by 53% QoQ and by 16% YoY: https://fullratio.com/stocks/nasdaq-pepg/pepgen

User Image Stock_Titan Posted - 3 months ago

$PEPG PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights https://www.stocktitan.net/news/PEPG/pep-gen-reports-second-quarter-2024-financial-results-and-recent-6n93mflmf3zk.html

User Image TheLearnerEarner Posted - 3 months ago

$PEPG added HIGHLY SPECULATIVE stock swing trade - healthcare - small cap - 3/9 F-Score - 1.8x relative volume - 4x analysts buy rating - revenue is forecast to grow 61.53% per year - short term gains (with potential for a medium term upgrade) 💱 RSI: 24.33 (oversold) 📊 Analyst Price Target: $20.20 - $27.30 (117.91% - 190.73% above Price) 🌟 Range (52w) $3.72 - $19.30 💰 NEWSDESK (article idea is for PEPG only) 📰 https://uk.finance.yahoo.com/news/down-39-63-4-weeks-133502199.html

User Image NVDAMillionaire Posted - 3 months ago

$PEPG PepGen Inc. (NASDAQ:PEPG): Advancing Next-Generation Oligonucleotide Therapies for Severe Neuromuscular and Neurological Diseases http://beyondspx.com/2024/08/02/pepgen-inc-nasdaqpepg-advancing-next-generation-oligonucleotide-therapies-for-severe-neuromuscular-and-neurological-diseases/

User Image PenkeTrading Posted - 3 months ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of PepGen Ltd. Is that bullish or bearish? $PEPG #PEPG #nasdaq #tradingsignals #technicalanalysis

User Image Fullratio Posted - 3 months ago

$PEPG quick ratio has surged by 147% QoQ and by 69% YoY: https://fullratio.com/stocks/nasdaq-pepg/pepgen

User Image peepa Posted - 3 months ago

$PEPG do you think we will climb

User Image tradingtwenty Posted - 07/31/24

Top 5 stocks by highest volume percent change (today vs 3-month average): $NCNC 96075.98% 🔥 $MHUA 77356.72% $VCNX 2257.64% $QXO 1686/63% $PEPG 1415.26% Link: https://tradingtwenty.com/dashboard/trending/past

User Image Fredo76 Posted - 07/31/24

$PEPG Cup & Handle❓️ Webull wouldn't let me buy more 😂😭😭😭 but did get in $DH at $3.40🤷‍♂️

User Image tradethehalt Posted - 07/31/24

$PEPG the price is up 32.55% since we first alerted at 9:37am EDT.

User Image peepa Posted - 07/31/24

$PEPG will it go to 15 dollars

User Image jeffgosia6 Posted - 07/31/24

$PEPG out with 25% profit in 2 hrs...best of luck all

Analyst Ratings
HC Wainwright & Co. Buy Aug 1, 24
Wedbush Outperform Jul 31, 24
HC Wainwright & Co. Buy May 15, 24
Wedbush Outperform May 15, 24
Wedbush Outperform Mar 7, 24
Wedbush Outperform Jan 30, 24
HC Wainwright & Co. Buy Sep 7, 23
HC Wainwright & Co. Buy Aug 9, 23
Stifel Buy Jun 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McArthur James G President and CEO President and CEO Nov 30 Buy 4.165 1,694 7,056 1,694 12/05/23
McArthur James G President and CEO President and CEO Jun 08 Sell 16.04 2,381 38,191 06/09/23
McArthur James G President and CEO President and CEO Jun 08 Option 2.71 2,381 6,453 2,381 06/09/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Mar 24 Sell 20 392 7,840 03/28/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Mar 24 Option 10.88 392 4,265 392 03/28/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Feb 06 Sell 17.07 6,000 102,420 02/08/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Feb 06 Option 10.88 6,000 65,280 644 02/08/23
KEATING LAURIE Director Director May 06 Buy 12.00 4,166 49,992 4,166 01/19/23